Wellington Management Group LLP Iovance Biotherapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 129,482 shares of IOVA stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,482

Previous 117,418 10.27%

Holding current value

$1.05 Million

Previous $941,000 29.12%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $87,825 - $143,561	12,064 Added 10.27%	129,482 $1.22 Million
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $56,008 - $102,153	7,199 Added 6.53%	117,418 $941,000
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $836,562 - $1.93 Million	110,219 New	110,219 $1.63 Million
Q4 2023 Feb 12, 2024	BUY	$3.3 - $8.89 $511,978 - $1.38 Million	155,145 New	155,145 $1.26 Million
Q3 2023 Nov 14, 2023	SELL	$4.44 - $8.79 $122,663 - $242,841	-27,627 Reduced 21.38%	101,573 $462,000
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $135,532 - $229,091	-25,286 Reduced 16.37%	129,200 $909,000
Q1 2023 May 12, 2023	SELL	$5.53 - $8.22 $1.48 Million - $2.2 Million	-267,124 Reduced 63.36%	154,486 $943,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $6.84 Million - $12.2 Million	-1,217,925 Reduced 74.28%	421,610 $2.69 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $2.91 Million - $4 Million	305,473 Added 22.9%	1,639,535 $15.7 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $63.5 Million - $182 Million	-9,954,664 Reduced 88.18%	1,334,062 $14.7 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $21.1 Million - $32.6 Million	1,704,644 Added 17.79%	11,288,726 $188 Million
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $11.3 Million - $18.9 Million	684,552 Added 7.69%	9,584,082 $183 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $33.5 Million - $43.9 Million	1,648,287 Added 22.73%	8,899,530 $219 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $58,559 - $118,589	3,586 Added 0.05%	7,251,243 $189 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $46.9 Million - $86 Million	1,635,725 Added 29.15%	7,247,657 $229 Million
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $139 Million - $250 Million	4,964,622 Added 766.96%	5,611,932 $260 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $58,885 - $77,028	-2,122 Reduced 0.33%	647,310 $21.3 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $30.6 Million - $46.1 Million	-1,124,940 Reduced 63.4%	649,432 $17.8 Million
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $12.3 Million - $24.4 Million	-629,332 Reduced 26.18%	1,774,372 $53.1 Million
Q4 2019 Feb 11, 2020	BUY	$17.95 - $29.41 $43.1 Million - $70.7 Million	2,403,704 New	2,403,704 $66.5 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Iovance Biotherapeutics, Inc. Transaction History